SIGA technologies’ TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses
On Jan. 2, 2025, SIGA Technologies announced that its antiviral treatment TEPOXX (tecovirimat 200 mg capsules), marketed as…
-
-
Action needed to improve U.S. Smallpox readiness and diagnostics, vaccines, and therapeutics
On Mar. 26, 2024, the National Academies of Sciences, Engineering, and Medicine released a report that says that…
